These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

489 related items for PubMed ID: 28277842

  • 1. An update on the safety of psychostimulants for the treatment of attention-deficit/hyperactivity disorder.
    Groenman AP, Schweren LJ, Dietrich A, Hoekstra PJ.
    Expert Opin Drug Saf; 2017 Apr; 16(4):455-464. PubMed ID: 28277842
    [Abstract] [Full Text] [Related]

  • 2. [Efficacy and safety of stimulants and non-stimulants in adults with attention deficit hyperactivity disorder (ADHD)].
    Golubchik P, Sever J, Weizman A.
    Harefuah; 2011 Oct; 150(10):788-90, 814. PubMed ID: 22111124
    [Abstract] [Full Text] [Related]

  • 3. [Supervised off-label prescribing of methylphenidate in adult ADHD].
    Carton L, Dondaine T, Deheul S, Marquié C, Brigadeau F, Amad A, Devos D, Danel T, Bordet R, Cottencin O, Gautier S, Ménard O.
    Encephale; 2019 Feb; 45(1):74-81. PubMed ID: 30122296
    [Abstract] [Full Text] [Related]

  • 4. Once-daily OROS methylphenidate is safe and well tolerated in adolescents with attention-deficit/hyperactivity disorder.
    McGough JJ, McBurnett K, Bukstein O, Wilens TE, Greenhill L, Lerner M, Stein M.
    J Child Adolesc Psychopharmacol; 2006 Jun; 16(3):351-6. PubMed ID: 16768642
    [Abstract] [Full Text] [Related]

  • 5. Safe and effective methylphenidate therapy in a pediatric patient with glaucoma.
    Lewis H, Lewis J.
    Atten Defic Hyperact Disord; 2012 Mar; 4(1):37-9. PubMed ID: 22311620
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Stimulants: use and abuse in the treatment of attention deficit hyperactivity disorder.
    Fone KC, Nutt DJ.
    Curr Opin Pharmacol; 2005 Feb; 5(1):87-93. PubMed ID: 15661631
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Safety of therapeutic methylphenidate in adults: a systematic review of the evidence.
    Godfrey J.
    J Psychopharmacol; 2009 Mar; 23(2):194-205. PubMed ID: 18515459
    [Abstract] [Full Text] [Related]

  • 11. Disordered sleep in pediatric patients with attention deficit hyperactivity disorder: an overview.
    Ganelin-Cohen E, Ashkenasi A.
    Isr Med Assoc J; 2013 Nov; 15(11):705-9. PubMed ID: 24511653
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Prescribing ritalin in combined modality management of hyperactivity with attention deficit].
    Bricard C, Boidein F.
    Encephale; 2001 Nov; 27(5):435-43. PubMed ID: 11760693
    [Abstract] [Full Text] [Related]

  • 14. Long-term tolerability of the methylphenidate transdermal system in pediatric attention-deficit/hyperactivity disorder: a multicenter, prospective, 12-month, open-label, uncontrolled, phase III extension of four clinical trials.
    Findling RL, Wigal SB, Bukstein OG, Boellner SW, Abikoff HB, Turnbow JM, Civil R.
    Clin Ther; 2009 Aug; 31(8):1844-55. PubMed ID: 19808143
    [Abstract] [Full Text] [Related]

  • 15. How high a dose of stimulant medication in adult attention deficit hyperactivity disorder?
    Sachdev PS, Trollor JN.
    Aust N Z J Psychiatry; 2000 Aug; 34(4):645-50. PubMed ID: 10954396
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. European, randomized, phase 3 study of lisdexamfetamine dimesylate in children and adolescents with attention-deficit/hyperactivity disorder.
    Coghill D, Banaschewski T, Lecendreux M, Soutullo C, Johnson M, Zuddas A, Anderson C, Civil R, Higgins N, Lyne A, Squires L.
    Eur Neuropsychopharmacol; 2013 Oct; 23(10):1208-18. PubMed ID: 23332456
    [Abstract] [Full Text] [Related]

  • 18. Long-term use of stimulants in children with attention deficit hyperactivity disorder: safety, efficacy, and long-term outcome.
    Hechtman L, Greenfield B.
    Paediatr Drugs; 2003 Oct; 5(12):787-94. PubMed ID: 14658920
    [Abstract] [Full Text] [Related]

  • 19. Effects of methylphenidate on body index and physical fitness in Korean children with attention deficit hyperactivity disorder.
    Kang KD, Yun SW, Chung U, Kim TH, Park JH, Park IH, Han DH.
    Hum Psychopharmacol; 2016 Mar; 31(2):76-82. PubMed ID: 26756111
    [Abstract] [Full Text] [Related]

  • 20. An expert opinion on methylphenidate treatment for attention deficit hyperactivity disorder in pediatric patients with epilepsy.
    Baptista-Neto L, Dodds A, Rao S, Whitney J, Torres A, Gonzalez-Heydrich J.
    Expert Opin Investig Drugs; 2008 Jan; 17(1):77-84. PubMed ID: 18095920
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.